Patents by Inventor Helene Plotnicky

Helene Plotnicky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine
    Publication number: 20090181042
    Abstract: The present invention relates to the Respiratory Syncytial Virus, and more particularly to the identification of novel antigens which are useful in particular for the therapeutic and prophylactic treatment of conditions caused by this virus. The present invention relates to methods of generating and/or increasing an immunogenic response directed against Respiratory Syncytial Virus, including subgroups A and B.
    Type: Application
    Filed: March 2, 2009
    Publication date: July 16, 2009
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Nathalie Corvaia, Thien Ngoc Nguyen, Alain Beck, Helene Plotnicky
  • Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine
    Publication number: 20090036367
    Abstract: The present invention relates to the Respiratory Syncytial Virus, and more particularly to the identification of novel antigens which are useful in particular for the therapeutic and prophylactic treatment of conditions caused by this virus. The present invention relates to methods of generating and/or increasing an immunogenic response directed against Respiratory Syncytial Virus, including subgroups A and B.
    Type: Application
    Filed: November 16, 2007
    Publication date: February 5, 2009
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Nathalie Corvaia, Thien Nguyen Ngoc, Alain Beck, Helene Plotnicky
  • Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine
    Publication number: 20040175395
    Abstract: The invention concerns novel immunogenic peptides derived from the RSV G protein of the sub-group A or B comprising at least: a first peptide derived from the BRSV G protein of sub-group A or B including at least in position 173, 176, 182 and 186 a cysteine and whereof the C-terminal end includes at most the amino acid in position 192; and a second peptide derived from the RSV protein of sub-group A or B, said second peptide being located downstream of said first protein, so that the immunogenic peptide produced has a disulphide bond linking residues 173 and 186 and a second disulphide bond linking residues 176 and 182.
    Type: Application
    Filed: January 20, 2004
    Publication date: September 9, 2004
    Inventors: Nathalie Corvaia, Thien Nyugen Ngoc, Alain Beck, Helene Plotnicky